Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IGF-1R antibody and its use as addressing vehicle for the treatment of cancer

IGF-1R antibody and its use as addressing vehicle for the treatment of cancer

US Patent 11365259 · Granted Jun 21, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Composition for the treatment of IGF-1R expressing cancer2020
Composition for the treatment of IGF-1R expressing cancer2020
Composition for the treatment of IGF-1R expressing cancer2020
Composition for the treatment of IGF-1R expressing cancer2020